US Tech Biotechnology Total Retu XNBI Indice
7727.42 USD
{{ price }}
-0.747224%
{{change_pct}}%
PAYS
États-Unis
Marché
Tech Market
Plus Haut - Plus Bas [24H]
7631.91
-
7847.35 USD
Nombre de composants
190
US Tech Biotechnology Total Retu Graphique des prix
Top 5 Gagnants au Cours des Dernières 24 Heures
| KPTI | Karyopharm Therapeutics | +28.68% | |
|---|---|---|---|
| DERM | Journey Medical | +6.04% | |
| INO | Inovio Pharmaceuticals | +5.48% | |
| BIIB | Biogen | +5.34% | |
| MNKD | MannKind | +4.92% |
Top 5 Perdants au Cours des Dernières 24 Heures
| NVAX | Novavax | -9.26% | |
|---|---|---|---|
| CGEN | Compugen | -7.55% | |
| MCRB | Seres Therapeutics | -7.39% | |
| ILMN | Illumina | -4.76% | |
| LXRX | Lexicon Pharmaceuticals | -4.49% |
US Tech Biotechnology Total Retu XNBI APERÇU FINANCIER ET COMMERCIAL
| US Tech Biotechnology Total Retu Prix de l'Indice | 7727.42 USD |
| Dernière clôture | 7766.57 USD |
| Ouverture | 7769.91 USD |
| Offre | 0 USD x 0 |
| Demande | 0 USD x 0 |
| Variation du jour | 7753.57 - 7853.12 USD |
| Plage sur 52 semaines | 7753.57 - 7853.12 USD |
| Volume | 0 USD |
| Volume moyen | N/A |
Informations de trading
US Tech Biotechnology Total Retu Historique des prix de l'Indice
| Plus haut sur 52 semaines | 7853.12 USD |
| Plus bas sur 52 semaines | 7753.57 USD |
| Moyenne mobile sur 50 jours | N/A |
| Moyenne mobile sur 200 jours | N/A |
XNBI Statistiques de l'indice
| Volume moyen (3 mois) | N/A |
| Volume journalier moyen (10 jours) | N/A |
Questions et réponses concernant l'indice US Tech Biotechnology Total Retu
Quel est le cours actuel de l'Indice XNBI ?
Le prix de l'Indice US Tech Biotechnology Total Retu XNBI aujourd'hui est de 7727.42 USD.
Comment acheter l'Indice US Tech Biotechnology Total Retu ?
Vous pouvez acheter l'indice XNBI sur la plateforme Tech Market. Contactez votre conseiller financier pour choisir un courtier.
Quel est le symbole boursier de l'Indice US Tech Biotechnology Total Retu ?
Le symbole boursier ou ticker de l'Indice US Tech Biotechnology Total Retu est XNBI.
Combien de composants contient l'Indice US Tech Biotechnology Total Retu ?
L'Indice US Tech Biotechnology Total Retu contient 190 composants.
À quel pays appartient l'Indice US Tech Biotechnology Total Retu ?
L'Indice US Tech Biotechnology Total Retu fait référence à États-Unis.
À quelle bourse appartient l'Indice US Tech Biotechnology Total Retu ?
L'Indice US Tech Biotechnology Total Retu fait référence à la bourse Tech Market.
US Tech Biotechnology Total Retu COMPOSANTS
| Nom Nom | Prix Prix |
24h% 7j Graphique 24h%&7j |
Cap. du marché Cap. du marché | VOL Volume | 24h bas | 24h de haut | Cap. du marché | PER | BPA |
|---|
| Nom Nom | Prix Prix |
24h% 7j Graphique 24h%&7j |
Cap. du marché Cap. du marché | VOL Volume | 24h bas | 24h de haut | Cap. du marché | PER | BPA |
|---|---|---|---|---|---|---|---|---|---|
|
|
{{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.pe }} | {{ item.eps }} {{ item.eps_usd }} |
Amgen
AMGN
US
|
$447.28 — |
+2.04
|
$241.81B — | $3.10M — | $437.19 — | $450.98 — | $241.81B — | 27.78 | $16.10 — |
|
Gilead Sciences
GILD
US
|
$157.19 — |
+2.36
|
$194.91B — | $6.21M — | $153.00 — | $157.42 — | $194.91B — | 0 | -$2.65 — |
|
Vertex Pharmaceuticals
VRTX
US
|
$535.17 — |
+2.03
|
$135.56B — | $1.64M — | $521.29 — | $537.73 — | $135.56B — | 31.16 | $17.17 — |
|
Regeneron Pharmaceuticals
REGN
US
|
$819.09 — |
+1.67
|
$84.33B — | $852.29K — | $800.00 — | $825.52 — | $84.33B — | 20.25 | $40.44 — |
|
Illumina
ILMN
US
|
$269.40 — |
-4.76
|
$40.68B — | $2.22M — | $257.31 — | $283.55 — | $40.68B — | 50.26 | $5.36 — |
|
Biogen
BIIB
US
|
$253.84 — |
+5.34
|
$37.51B — | $2.24M — | $240.05 — | $254.41 — | $37.51B — | 45.08 | $5.63 — |
|
Alnylam Pharmaceuticals
ALNY
US
|
$227.28 — |
+0.97
|
$30.41B — | $2.21M — | $223.80 — | $229.82 — | $30.41B — | 38.32 | $5.93 — |
|
United Therapeutics
UTHR
US
|
$584.79 — |
+3.78
|
$25.08B — | $895.44K — | $562.86 — | $590.76 — | $25.08B — | 20.94 | $27.92 — |
|
Incyte
INCY
US
|
$116.93 — |
+3.08
|
$23.70B — | $2.24M — | $112.76 — | $117.17 — | $23.70B — | 14.89 | $7.85 — |
|
Insmed
INSM
US
|
$95.06 — |
+1.08
|
$20.76B — | $3.10M — | $93.35 — | $95.59 — | $20.76B — | 0 | -$4.10 — |
|
Exelixis
EXEL
US
|
$65.31 — |
+1.13
|
$16.18B — | $1.71M — | $64.33 — | $65.50 — | $16.18B — | 20.60 | $3.17 — |
|
Neurocrine Biosciences
NBIX
US
|
$143.29 — |
+1.4
|
$14.57B — | $1.24M — | $140.75 — | $143.83 — | $14.57B — | 21.01 | $6.82 — |
|
Halozyme Therapeutics
HALO
US
|
$124.54 — |
-0.23
|
$14.14B — | $5.10M — | $121.66 — | $124.72 — | $14.14B — | 36.41 | $3.42 — |
|
Jazz Pharmaceuticals
JAZZ
US
|
$214.65 — |
+1.26
|
$13.93B — | $783.80K — | $210.26 — | $215.19 — | $13.93B — | 14.71 | $14.59 — |
|
Bio-Techne
TECH
US
|
$72.62 — |
-0.03
|
$11.39B — | $4.16M — | $72.51 — | $72.69 — | $11.39B — | 62.60 | $1.16 — |
|
Repligen
RGEN
US
|
$178.71 — |
-0.72
|
$11.35B — | $1.27M — | $176.00 — | $185.03 — | $11.35B — | 244.80 | $0.73 — |
|
BioMarin Pharmaceutical
BMRN
US
|
$56.63 — |
+2.57
|
$10.96B — | $2.40M — | $55.02 — | $56.91 — | $10.96B — | 153.05 | $0.37 — |
|
Qiagen
QGEN
US
|
$50.22 — |
+0.44
|
$10.37B — | $40.83M — | $49.90 — | $50.52 — | $10.37B — | 25.49 | $1.97 — |
|
Arrowhead Pharmaceuticals
ARWR
US
|
$58.36 — |
-0.82
|
$8.22B — | $1.04M — | $56.97 — | $59.90 — | $8.22B — | 0 | -$2.26 — |
|
Alkermes
ALKS
US
|
$44.18 — |
+1.61
|
$7.41B — | $1.83M — | $43.46 — | $44.68 — | $7.41B — | 116.26 | $0.38 — |
- {{ link.label }} {{link}}
